Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
McNeil Nutritionals is a prominent consumer healthcare company specializing in nutritional products and dietary supplements. Formerly a division of Johnson & Johnson, the company became part of Kenvue following the 2023 spin-off of J&J's consumer health business. McNeil Nutritionals is widely recognized for developing and marketing market-leading brands such as Lactaid, which provides lactase enzyme supplements for lactose intolerance, and Benecol, which focuses on cholesterol management through plant stanol esters. Although the company famously launched and grew the Splenda brand, that business was sold to Heartland Food Products Group in 2015. Today, McNeil Nutritionals continues to focus on evidence-based nutritional interventions that address common metabolic and digestive health needs. The company operates as a commercial-stage entity with a global footprint in the over-the-counter and functional food markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on McNeil Nutritionals.